We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial

News   May 27, 2010

 
Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
 
 
 

RELATED ARTICLES

Should You Eat a Low-gluten Diet?

News

When healthy people eat a reduced-gluten and fiber-rich diet they experience less intestinal discomfort and bloating but this is more likely due to a change in composition of dietary fibers than gluten itself.

READ MORE

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE